OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants
Zhaochun Chen, Peng Zhang, Yumiko Matsuoka, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 13
Zhaochun Chen, Peng Zhang, Yumiko Matsuoka, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 13
Showing 13 citing articles:
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 189-199
Open Access | Times Cited: 283
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 189-199
Open Access | Times Cited: 283
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 282
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 282
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 96
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 96
Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-analysis
Kaiming Tao, Philip L. Tzou, Sergei L. Kosakovsky Pond, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 77
Kaiming Tao, Philip L. Tzou, Sergei L. Kosakovsky Pond, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 77
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 32
William R. Strohl, Zhiqiang Ku, Zhiqiang An, et al.
BioDrugs (2022) Vol. 36, Iss. 3, pp. 231-323
Open Access | Times Cited: 32
New SARS-CoV-2 Omicron variant — clinical picture, treatment, prevention (literature review)
V.I. Vechorko, О. В. Аверков, А. А. Зимин
CARDIOVASCULAR THERAPY AND PREVENTION (2022) Vol. 21, Iss. 6, pp. 3228-3228
Open Access | Times Cited: 14
V.I. Vechorko, О. В. Аверков, А. А. Зимин
CARDIOVASCULAR THERAPY AND PREVENTION (2022) Vol. 21, Iss. 6, pp. 3228-3228
Open Access | Times Cited: 14
Sera Metabolomics Characterization of Patients at Different Stages in Wuhan Identifies Critical Biomarkers of COVID-19
Meijia Gu, Huaqin Pan, Yuncong Yuan, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 10
Meijia Gu, Huaqin Pan, Yuncong Yuan, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 10
A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern
Hilal Ahmad Parray, Naveen Narayanan, Sonal Garg, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 12, pp. e1010994-e1010994
Open Access | Times Cited: 10
Hilal Ahmad Parray, Naveen Narayanan, Sonal Garg, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 12, pp. e1010994-e1010994
Open Access | Times Cited: 10
Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis
David J. McConnell, Marie Harte, Cathal Walsh, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
David J. McConnell, Marie Harte, Cathal Walsh, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
A broadly neutralising monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV2 variant of concerns
Rajesh Kumar, Hilal Parray, Naveen Narayan, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 3
Rajesh Kumar, Hilal Parray, Naveen Narayan, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 3
Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-Analysis
Kaiming Tao, Philip L. Tzou, Sergei L. Kosakovsky Pond, et al.
(2022)
Open Access | Times Cited: 3
Kaiming Tao, Philip L. Tzou, Sergei L. Kosakovsky Pond, et al.
(2022)
Open Access | Times Cited: 3
Máscaras pandêmicas: uma revisão sistemática sobre os impactos da máscara no reconhecimento das emoções
THIAGO HENRIQUE DE MORAES DANTAS, Julián Tejada, Raquel Meister Ko. Freitag
Texto Livre Linguagem e Tecnologia (2023) Vol. 16
Open Access
THIAGO HENRIQUE DE MORAES DANTAS, Julián Tejada, Raquel Meister Ko. Freitag
Texto Livre Linguagem e Tecnologia (2023) Vol. 16
Open Access
Development of practical techniques for simultaneous detection and distinction of current and emerging SARS-CoV-2 variants
Tuocen Fan, Chengjie Li, X G Liu, et al.
Analytical Sciences (2023) Vol. 39, Iss. 11, pp. 1839-1856
Open Access
Tuocen Fan, Chengjie Li, X G Liu, et al.
Analytical Sciences (2023) Vol. 39, Iss. 11, pp. 1839-1856
Open Access
